Abivax (AAVXF) Shares Outstanding (2023 - 2025)

Abivax has reported Shares Outstanding over the past 3 years, most recently at $91.4 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $91.4 million for Q4 2025, up 35.05% from a year ago — trailing twelve months through Dec 2025 was $91.4 million (up 35.05% YoY), and the annual figure for FY2025 was $88.7 million, up 29.41%.
  • Shares Outstanding for Q4 2025 was $91.4 million at Abivax, up from $67.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding for AAVXF hit a ceiling of $91.4 million in Q4 2025 and a floor of $67.7 million in Q4 2024.
  • Median Shares Outstanding over the past 3 years was $67.7 million (2023), compared with a mean of $75.6 million.
  • Biggest five-year swings in Shares Outstanding: decreased 0.02% in 2024 and later surged 35.05% in 2025.
  • Abivax's Shares Outstanding stood at $67.7 million in 2023, then decreased by 0.02% to $67.7 million in 2024, then surged by 35.05% to $91.4 million in 2025.
  • The last three reported values for Shares Outstanding were $91.4 million (Q4 2025), $67.7 million (Q4 2024), and $67.7 million (Q4 2023) per Business Quant data.